Related references
Note: Only part of the references are listed.Detection of Molecular Markers of Antiviral Resistance in Influenza A (H5N1) Viruses Using a Pyrosequencing Method
Varough M. Deyde et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Pyrosequencing as a tool to detect molecular markers of resistance to neuraminidase inhibitors in seasonal influenza A viruses
Varough M. Deyde et al.
ANTIVIRAL RESEARCH (2009)
Novel virus discovery in field-collected mosquito larvae using an improved system for rapid determination of viral RNA sequences (RDV ver4.0)
Takuya Yamao et al.
ARCHIVES OF VIROLOGY (2009)
Infections With Oseltamivir-Resistant Influenza A(H1N1) Virus in the United States
Nila J. Dharan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Differential patterns of amantadine-resistance in influenza A (H3N2) and (H1N1) isolates in Toronto, Canada
Rachel R. Higgins et al.
JOURNAL OF CLINICAL VIROLOGY (2009)
Low-Abundance Drug-Resistant Viral Variants in Chronically HIV-Infected, Antiretroviral Treatment-Naive Patients Significantly Impact Treatment Outcomes
Birgitte B. Simen et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Use of Massively Parallel Ultradeep Pyrosequencing To Characterize the Genetic Diversity of Hepatitis B Virus in Drug-Resistant and Drug-Naive Patients and To Detect Minor Variants in Reverse Transcriptase and Hepatitis B S Antigen
Mariacarmela Solmone et al.
JOURNAL OF VIROLOGY (2009)
Massively parallel pyrosequencing highlights minority variants in the HIV-1 env quasispecies deriving from lymphomonocyte sub-populations
Gabriella Rozera et al.
RETROVIROLOGY (2009)
Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008
Tiffany G. Sheu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Mutations of neuraminidase implicated in neuraminidase inhibitors resistance
Olivier Ferraris et al.
JOURNAL OF CLINICAL VIROLOGY (2008)
Increased incidence of adamantane-resistant influenza A(H1N1) and A(H3N2) viruses during the 2006-2007 influenza season in Japan - Reply
Varough M. Deyde et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Ensemble-based virtual screening reveals potential novel antiviral compounds for avian influenza neuraminidase
Lily S. Cheng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Detection of human virulence signatures in H5N1
Nicole Waybright et al.
JOURNAL OF VIROLOGICAL METHODS (2008)
A new and rapid genotypic assay for the detection of neuraminidase inhibitor resistant influenza A viruses of subtype H1N1, H3N2, and H5N1
Susanne Duwe et al.
JOURNAL OF VIROLOGICAL METHODS (2008)
Rapid molecular detection of the H275Y oseltamivir resistance gene mutation in circulating influenza A (H1N1) viruses
Michael J. Carr et al.
JOURNAL OF VIROLOGICAL METHODS (2008)
Structural Characterization of the 1918 Influenza Virus H1N1 Neuraminidase
Xiaojin Xu et al.
JOURNAL OF VIROLOGY (2008)
Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants
Patrick J. Collins et al.
NATURE (2008)
Enzymatic properties of the neuraminidase of seasonal H1N1 influenza viruses provide insights for the emergence of natural resistance to oseltamivir
Marie-Anne Rameix-Welti et al.
PLOS PATHOGENS (2008)
Newly Discovered Ebola Virus Associated with Hemorrhagic Fever Outbreak in Uganda
Jonathan S. Towner et al.
PLOS PATHOGENS (2008)
Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide
Varough M. Deyde et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Design and validation of an H5 TaqMan real-time one-step reverse transcription-PCR and confirmatory assays for diagnosis and verification of influenza A virus H5 infections in humans
Joanna S. Ellis et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
Analysis of read length limiting factors in Pyrosequencing chemistry
Foad Mashayekhi et al.
ANALYTICAL BIOCHEMISTRY (2007)
Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitors
Shuji Hatakeyama et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Susceptibility of highly pathogenic A(H5N1) avian influenza viruses to the neuraminidase inhibitors and adamantanes
A. C. Hurt et al.
ANTIVIRAL RESEARCH (2007)
Rapid and Highly Informative Diagnostic Assay for H5N1 Influenza Viruses
Nader Pourmand et al.
PLOS ONE (2006)
Quantitation of site-specific HPV 16 DNA methylation by pyrosequencing
Mangalathu S. Rajeevan et al.
JOURNAL OF VIROLOGICAL METHODS (2006)
Natural variation can significantly alter the sensitivity of influenza A (H5N1) viruses to oseltamivir
M. A. Rameix-Welti et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design
Rupert J. Russell et al.
NATURE (2006)
Genomic signatures of human versus avian influenza a viruses
Guang-Wu Chen et al.
EMERGING INFECTIOUS DISEASES (2006)
Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use
Arnold S. Monto et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Distribution of amantadine-resistant H5N1 avian influenza variants in Asia
Chung-Lam Cheung et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Recovery of drug-resistant influenza virus from immunocompromised patients: A case series
MG Ison et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States
RA Bright et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Pyrosequencing: History, biochemistry and future
A Ahmadian et al.
CLINICA CHIMICA ACTA (2006)
Brief report - Oseltamivir resistance during treatment of influenza A (H5N1) infection
MD de Jong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern
RA Bright et al.
LANCET (2005)
Oseltamivir (Tamiflu®) and its potential for use in the event of an influenza pandemic
P Ward et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Characterization of recombinant influenza B viruses with key neuraminidase inhibitor resistance mutations
D Jackson et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Both risk alleles for FcγRIIA and FcγRIIIA are susceptibility factors for SLE:: a unifying hypothesis
V Magnusson et al.
GENES AND IMMUNITY (2004)
Pyrosequencing technology as a method for the diagnosis of multiple endocrine neoplasia type 2
KE Kruckeberg et al.
CLINICAL CHEMISTRY (2004)
Resistant influenza A viruses in children treated with oseltarnivir: descriptive study
M Kiso et al.
LANCET (2004)
Multiple group-specific sequencing primers for reliable and rapid DNA sequencing
B Gharizadeh et al.
MOLECULAR AND CELLULAR PROBES (2003)
Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir
J McKimm-Breschkin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Determination of hepatitis C virus genotype by Pyrosequencing
E Elahi et al.
JOURNAL OF VIROLOGICAL METHODS (2003)
Multiple-primer DNA sequencing method
B Gharizadeh et al.
ELECTROPHORESIS (2003)
Evaluation of neuraminidase enzyme assays using different substrates to measure susceptibility of influenza virus clinical isolates to neuraminidase inhibitors: Report of the neuraminidase inhibitor susceptibility network
NT Wetherall et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2003)
Mortality associated with influenza and respiratory syncytial virus in the United States
WW Thompson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Assaying susceptibility of avian and other influenza A viruses to Zanamivir: Comparison of fluorescent and chemiluminescent neuraminidase assays
BA Mungall et al.
AVIAN DISEASES (2003)
Evaluation of a potential epigenetic biomarker by quantitative methyl-single nucleotide polymorphism analysis
K Uhlmann et al.
ELECTROPHORESIS (2002)
Characterization of 2 influenza A(H3N2) clinical isolates with reduced susceptibility to neuraminidase inhibitors due to mutations in the hemagglutinin gene
Y Abed et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Estimation of single nucleotide polymorphism allele frequency in DNA pools by using Pyrosequencing
JD Gruber et al.
HUMAN GENETICS (2002)
Gene expression analysis by signature pyrosequencing
C Agaton et al.
GENE (2002)
Discovery of single nucleotide polymorphisms and mutations by pyrosequencing
M Ronaghi et al.
COMPARATIVE AND FUNCTIONAL GENOMICS (2002)
Long-read pyrosequencing using pure 2′-deoxyadenosine-5′-O′-(1-thiotriphosphate) Sp-isomer
B Gharizadeh et al.
ANALYTICAL BIOCHEMISTRY (2002)
Detection of influenza virus resistance to neuraminidase inhibitors by an enzyme inhibition assay
LV Gubareva et al.
ANTIVIRAL RESEARCH (2002)
Prolonged excretion of amantadine-resistant influenza A virus quasi species after cessation of antiviral therapy in an Immunocompromised patient
G Boivin et al.
CLINICAL INFECTIOUS DISEASES (2002)
Classification, identification and subtyping of bacteria based on pyrosequencing and signature matching of 16S rDNA fragments
J Jonasson et al.
APMIS (2002)
Pyrosequencing as a method for grouping of Listeria monocytogenes strains on the basis of single-nucleotide polymorphisms in the inlB gene
H Unnerstad et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2001)
Mutations in the region encoding the von Willebrand factor A domain of matrilin-3 are associated with multiple epiphyseal dysplasia
KL Chapman et al.
NATURE GENETICS (2001)
Rapid molecular identification and subtyping of Helicobacter pylori by pyrosequencing of the 16S rDNA variable V1 and V3 regions
HJ Monstein et al.
FEMS MICROBIOLOGY LETTERS (2001)
Method enabling fast partial sequencing of cDNA clones
T Nordström et al.
ANALYTICAL BIOCHEMISTRY (2001)
Typing of human papillomavirus by pyrosequencing
B Gharizadeh et al.
LABORATORY INVESTIGATION (2001)
Position statement: global neuraminidase inhibitor susceptibility network
M Zambon et al.
ANTIVIRAL RESEARCH (2001)
Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir
LV Gubareva et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Oral oseltamivir treatment of influenza in children
RJ Whitley et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2001)
Monitoring resistance to human immunodeficiency virus type 1 protease inhibitors by pyrosequencing
D O'Meara et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2001)
Quantification of HIV-1 using multiple quantitative polymerase chain reaction standards and bioluminometric detection
M Nygren et al.
ANALYTICAL BIOCHEMISTRY (2001)
Single-nucleotide polymorphism analysis by pyrosequencing
A Ahmadian et al.
ANALYTICAL BIOCHEMISTRY (2000)
Incidence of amantadine-resistant influenza A viruses in sentinel surveillance sites and nursing homes in Niigata, Japan
H Masuda et al.
MICROBIOLOGY AND IMMUNOLOGY (2000)
Share Paper
